CUFinder

IGHO ONAKPOYA

IGHO ONAKPOYA

University of Oxford

H-index: 44

Europe-United Kingdom

Contact IGHO ONAKPOYA

About IGHO ONAKPOYA

IGHO ONAKPOYA, With an exceptional h-index of 44 and a recent h-index of 39 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of clinical effectiveness, adverse drug reactions, systematic review, meta-analysis, complex reviews.

His recent articles reflect a diverse array of research interests and contributions to the field:

Correction to “Naltrexone‐bupropion (Mysimba) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports.”

A Comparison of Signals of Designated Medical Events and Non-designated Medical Events: Results from a Scoping Review

The impact of the COVID-19 pandemic and associated disruptions in health-care provision on clinical outcomes in people with diabetes: a systematic review

Treatments for cough and common cold in children

Oro-faecal transmission of SARS-CoV-2: A systematic review of studies employing viral culture from gastrointestinal and other potential sources

Approved Combination Agents: Naltrexone-Bupropion

An Update to the Overview of Reviews: Risks of and From SARS-COV-2 Infection and COVID-19 in People With Diabetes

Side effects of drugs used in the treatment of tuberculosis and leprosy

IGHO ONAKPOYA Information

University

Position

___

Citations(all)

8318

Citations(since 2020)

5367

Cited By

5015

hIndex(all)

44

hIndex(since 2020)

39

i10Index(all)

78

i10Index(since 2020)

75

Email

University Profile Page

Google Scholar

IGHO ONAKPOYA Skills & Research Interests

clinical effectiveness

adverse drug reactions

systematic review

meta-analysis

complex reviews

Top articles of IGHO ONAKPOYA

Correction to “Naltrexone‐bupropion (Mysimba) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports.”

2024/4/8

A Comparison of Signals of Designated Medical Events and Non-designated Medical Events: Results from a Scoping Review

2024/2/24

Daniele Sartori
Daniele Sartori

H-Index: 7

The impact of the COVID-19 pandemic and associated disruptions in health-care provision on clinical outcomes in people with diabetes: a systematic review

2022/11

Georgia Salanti
Georgia Salanti

H-Index: 61

Thomy Tonia
Thomy Tonia

H-Index: 29

Alexander Holloway
Alexander Holloway

H-Index: 5

Nicola Low
Nicola Low

H-Index: 47

Matthias Egger
Matthias Egger

H-Index: 112

Seena Fazel
Seena Fazel

H-Index: 64

Ronald C Kessler
Ronald C Kessler

H-Index: 185

Christian Kieling
Christian Kieling

H-Index: 38

Vikram Patel
Vikram Patel

H-Index: 0

Andrea Cipriani
Andrea Cipriani

H-Index: 51

Stefan Leucht
Stefan Leucht

H-Index: 78

Treatments for cough and common cold in children

bmj

2024/1/25

Peter J Gill
Peter J Gill

H-Index: 17

Kathryn A Birnie
Kathryn A Birnie

H-Index: 22

Ann Van Den Bruel
Ann Van Den Bruel

H-Index: 28

Oro-faecal transmission of SARS-CoV-2: A systematic review of studies employing viral culture from gastrointestinal and other potential sources

2024

David Evans
David Evans

H-Index: 1

Igho Onakpoya
Igho Onakpoya

H-Index: 35

Annette Pluddemann
Annette Pluddemann

H-Index: 25

Carl Heneghan
Carl Heneghan

H-Index: 60

Approved Combination Agents: Naltrexone-Bupropion

2024

An Update to the Overview of Reviews: Risks of and From SARS-COV-2 Infection and COVID-19 in People With Diabetes

2023/12/1

Igho Onakpoya
Igho Onakpoya

H-Index: 35

Jessica Morgan
Jessica Morgan

H-Index: 1

Samuel Seidu
Samuel Seidu

H-Index: 20

Side effects of drugs used in the treatment of tuberculosis and leprosy

2023/9/15

Side effects of antihelminthic drugs

2023/9/15

Coinfection with Strongyloides and SARS-CoV-2: A Systematic Review

2023/4/25

Carl Heneghan
Carl Heneghan

H-Index: 60

David Evans
David Evans

H-Index: 1

Biomarkers of potential harm in people switching from smoking tobacco to exclusive e‐cigarette use, dual use or abstinence: secondary analysis of Cochrane systematic review of …

2023/3

Annika Theodoulou
Annika Theodoulou

H-Index: 7

Peter Hajek
Peter Hajek

H-Index: 36

Chris Bullen
Chris Bullen

H-Index: 38

Nicola Lindson
Nicola Lindson

H-Index: 16

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: a scoping review of the global literature

2023/2

Daniele Sartori
Daniele Sartori

H-Index: 7

Viral cultures, cycle threshold values and viral load estimation for assessing SARS-CoV-2 infectiousness in haematopoietic stem cell and solid organ transplant patients: a …

2023/2/1

David H Evans
David H Evans

H-Index: 19

Coinfection with Strongyloides and SARS-CoV-2: protocol for a systematic review (preprint)

2023/4/25

Carl Heneghan
Carl Heneghan

H-Index: 60

David Evans
David Evans

H-Index: 1

Utility of healthcare-worker-targeted antimicrobial stewardship interventions in hospitals of low-and lower-middle-income countries: a scoping review of systematic reviews

2023/1/1

Jong-Wook Ban
Jong-Wook Ban

H-Index: 3

Veronika Williams
Veronika Williams

H-Index: 15

International oncology drug approvals for multiregional or single-country clinical trials: A systematic review

2022/12/15

Min Zhang
Min Zhang

H-Index: 21

Igho Onakpoya
Igho Onakpoya

H-Index: 35

Viral cultures for assessing fomite transmission of SARS-CoV-2: a systematic review and meta-analysis

2022/12/1

David H Evans
David H Evans

H-Index: 19

Transmission of SARS-CoV-2 from pre and asymptomatic infected individuals: a systematic review update

2022/11/1

Transmission of SARS-CoV-2 associated with cruise ship travel: a systematic review

2022/10/9

Carl Heneghan
Carl Heneghan

H-Index: 60

David Evans
David Evans

H-Index: 1

A hierarchical framework for assessing transmission causality of respiratory viruses

2022/7/22

Elizabeth Spencer
Elizabeth Spencer

H-Index: 41

Igho Onakpoya
Igho Onakpoya

H-Index: 35

David Evans
David Evans

H-Index: 1

See List of Professors in IGHO ONAKPOYA University(University of Oxford)